Similarly, CD133 was found to be a CSC marker for hepatocellular carcinoma (HCC) in which cell proliferation was higher in CD133+ cells compared to CD133- cells, and in vivo experiments showed that CD133+ cells initiate significantly larger tumors [20]. The gene discussed is PROM1; the disease is hepatocellular carcinoma.